Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TDF, Lamivudine and Efavirenz in HIV/HBV Coinfection
NCT01751555Phase 4Completed
- Sponsor
- CNAIDS
- Start
- Feb 2011
- Primary completion
- Jun 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of tenofovir disoproxil fumarate in human immunodeficiency virus infection (HIV), hepatitis B (HBV), sponsored by CNAIDS. Started Feb 2011; status: completed.
02
Drugs
tenofovir disoproxil fumarate
03
Conditions
human immunodeficiency virus infection (HIV)hepatitis B (HBV)
Beyond the preview
Go deeper on NCT01751555.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01751555.